Vanessa Caceres

Contributing Writer

  • All
  • Deals
  • Devices and Diagnostics
  • Digital
  • Genetics
  • Pharma
Ranibizumab More Cost-Effective Than PRP

Ranibizumab More Cost-Effective Than PRP

The use of ranibizumab 0.5 mg for proliferative diabetic retinopathy (PDR) compared with panretinal photocoagulation (PRP) appeared to be more cost effective for patients with ...
Read More
CorneaGen Aims to End Corneal Blindness

CorneaGen Aims to End Corneal Blindness

CorneaGen’s approach to treating corneal blindness is to prevent it from ever occurring, said Monty Montoya, president and CEO, who added no other organization has ...
Read More